Guymer RH - Search Results

1

The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID study.

Arnold JJ, Markey CM, Kurstjens NP, Guymer RH. Arnold JJ, et al. Among authors: guymer rh. BMC Ophthalmol. 2016 Mar 24;16:31. doi: 10.1186/s12886-016-0207-3. BMC Ophthalmol. 2016. PMID: 27009515 Free PMC article. Clinical Trial.

2

New treatments in age-related macular degeneration.

Hooper CY, Guymer RH. Hooper CY, et al. Among authors: guymer rh. Clin Exp Ophthalmol. 2003 Oct;31(5):376-91. doi: 10.1046/j.1442-9071.2003.00683.x. Clin Exp Ophthalmol. 2003. PMID: 14516424 Review.

3

Iris colour, ethnic origin and progression of age-related macular degeneration.

Nicolas CM, Robman LD, Tikellis G, Dimitrov PN, Dowrick A, Guymer RH, McCarty CA. Nicolas CM, et al. Among authors: guymer rh. Clin Exp Ophthalmol. 2003 Dec;31(6):465-9. doi: 10.1046/j.1442-9071.2003.00711.x. Clin Exp Ophthalmol. 2003. PMID: 14641151

4

Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.

Essex RW, Qureshi SH, Cain MS, Harper CA, Guymer RH. Essex RW, et al. Among authors: guymer rh. Clin Exp Ophthalmol. 2003 Dec;31(6):476-81. doi: 10.1046/j.1442-9071.2003.00714.x. Clin Exp Ophthalmol. 2003. PMID: 14641153 Clinical Trial.

5

The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration.

Baird PN, Guida E, Chu DT, Vu HT, Guymer RH. Baird PN, et al. Among authors: guymer rh. Invest Ophthalmol Vis Sci. 2004 May;45(5):1311-5. doi: 10.1167/iovs.03-1121. Invest Ophthalmol Vis Sci. 2004. PMID: 15111582

6

Flicker perimetry losses in age-related macular degeneration.

Phipps JA, Dang TM, Vingrys AJ, Guymer RH. Phipps JA, et al. Among authors: guymer rh. Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3355-60. doi: 10.1167/iovs.04-0253. Invest Ophthalmol Vis Sci. 2004. PMID: 15326161

7

Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration.

Baird PN, Chu D, Guida E, Vu HT, Guymer R. Baird PN, et al. Am J Ophthalmol. 2004 Oct;138(4):665-6. doi: 10.1016/j.ajo.2004.04.053. Am J Ophthalmol. 2004. PMID: 15488805

8

HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?

Guymer RH, Chiu AW, Lim L, Baird PN. Guymer RH, et al. Surv Ophthalmol. 2005 Mar-Apr;50(2):194-206. doi: 10.1016/j.survophthal.2004.12.002. Surv Ophthalmol. 2005. PMID: 15749309 Review.

9

Treatment of age-related macular degeneration.

Bylsma GW, Guymer RH. Bylsma GW, et al. Among authors: guymer rh. Clin Exp Optom. 2005 Sep;88(5):322-34. doi: 10.1111/j.1444-0938.2005.tb06716.x. Clin Exp Optom. 2005. PMID: 16255691 Free article. Review.

10

Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration.

Baird PN, Islam FM, Richardson AJ, Cain M, Hunt N, Guymer R. Baird PN, et al. Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4194-8. doi: 10.1167/iovs.05-1285. Invest Ophthalmol Vis Sci. 2006. PMID: 17003406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters